Blu – Pagina 40 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Maggio 2, 2024 dario.olivero

Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants

Almeida OP, Fong Z, Hill Almeida LM, et al.
Diabetes Obes Metab. Pub. Online 23 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Early-onset hypertension and sex-specific residual risk for cardiovascular disease in type 2 diabetes

Ji H, Ebinger JE, Kwan AC, et al.
Diabetes Care. Pub. Online 24 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications

Dixit AA, Bateman BT, Hawn MT, et al.
JAMA. Pub. Online 22 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Effect of 5:2 regimens: energy-restricted diet or low-volume high-intensity interval training combined with resistance exercise on glycemic control and cardiometabolic health in adults with overweight/obesity and type 2 diabetes—a three-arm randomized controlled trial

Li M, Li J, Xu Y, et al.
Diabetes Care. Pub. Online 18 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Could glp-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions?

Rubin R
JAMA. Pub. Online 19 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Undiagnosed type 2 diabetes is common – intensified screening of established risk groups is imperative in Sweden: the SDPP cohort

Gudjonsdottir H, Tynelius P, Stattin NS, et al.
BMC Med. Pub. Online 19 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial

Kim JY, Jin SM, Kang ES, et al.
Diabetologia. Pub. Online 18 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Kidney and cardiovascular effectiveness of empagliflozin compared to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes

Edmonston D, Mulder H, Lydon E, et al.
Am J Cardiol. Pub. Online 17 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial

Kim JY, Jin SM, Sim KH, et al.
Diabetologia. Pub. Online 19 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Early-onset type 2 diabetes and tirzepatide treatment: A post hoc analysis from the surpass clinical trial program

Zeitler P, Galindo RJ, Davies MJ, et al.
Diabetes Care. Pub. Online 19 Apr 2024.

Leggi